Inflammation: Clinical Trials

77 trials for Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

77 terminated. 77 Phase 3, 20 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 377Terminated 77
Phase 220Terminated 20

Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation

Trials (filtered) newest first · largest first

All 77 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
Metoprolol Injection, saline 0.9% - Acute Respiratory Distress Syndrome (ARDS)
Phase 3TerminatedConsorcio Centro de Investigación Biomédica en Red (CIBER)142024-07-102026-06-02
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
SCY-078, Fluconazole, Echinocandin - Candidiasis, Invasive, Candidemia
Phase 3TerminatedScynexis, Inc.682022-08-032026-08-10
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
Lithium Carbonate, Placebo - Carotid Artery Diseases, Carotid Artery Stenosis
Phase 3TerminatedNegovsky Reanimatology Research Institute1072021-11-202025-09-25
Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock
Vitamin C, Placebo - Sepsis, Septic Shock
Phase 3TerminatedHospital Sirio-Libanes712021-08-012024-01-30
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
Meropenem - Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection
Phase 2 / Phase 3TerminatedHospital de Clinicas de Porto Alegre132021-05-042022-08-03
INB03 for the Treatment of Pulmonary Complications From COVID-19
INB03, Placebo - COVID-19
Phase 2 / Phase 3TerminatedInmune Bio, Inc.792020-10-212026-05-19
Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults
LAU-7b, Placebo oral capsule - COVID-19 Disease
Phase 2 / Phase 3TerminatedLaurent Pharmaceuticals Inc.3512020-08-182025-11-13
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
Hyperbaric oxygen - SARS (Severe Acute Respiratory Syndrome), Cytokine Storm
Phase 2 / Phase 3TerminatedKarolinska Institutet342020-06-032023-01-09
The Role of Resistant Starch in COVID-19 Infection
Dietary Supplement containing resistant starch, Placebo Starch - COVID-19
Phase 2 / Phase 3TerminatedYale University2262020-06-032022-10-05
Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)
Placebo, Ruxolitinib - COVID-19
Phase 3TerminatedIncyte Corporation2112020-05-242022-01-19
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
Tocilizumab - COVID, SARS Pneumonia
Phase 3TerminatedBeneficência Portuguesa de São Paulo1292020-05-082020-08-26
MSCs in COVID-19 ARDS
Remestemcel-L, Placebo - Mesenchymal Stromal Cells, Remestemcel-L
Phase 3TerminatedIcahn School of Medicine at Mount Sinai2232020-04-302022-04-25
The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 )
vitamin D3 - Crohn Disease
Phase 3TerminatedJantchou Prevost552020-02-072026-10-21
Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.
Albumin Human - Community-acquired Pneumonia, Hypoalbuminemia
Phase 3TerminatedJordi Carratala392019-10-312023-01-31
Evaluation of the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic Shock
Dexmedetomidine 100 Mcg/mL Intravenous Solution, 5% glucose Infusion solution - Septic Shock, Vasopressor Resistance
Phase 3TerminatedCentre Hospitalier Universitaire Dijon322019-10-272026-02-04
Albumin Replacement Therapy in Septic Shock
Albutein® 200 g/L or Plasbumin® 20 - Septic Shock
Phase 3TerminatedJena University Hospital4402019-10-212024-10-28
Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock
Vitamin C, Normal saline - Septic Shock
Phase 3TerminatedNew York Presbyterian Brooklyn Methodist Hospital32019-10-152020-02-10
Local Compression Seroma DIminution Objective (CLODIS)
Compression by chest bandage urgo K2®, punctures - Breast Cancer, Mastectomy
Phase 3TerminatedCentre Francois Baclesse602018-11-182025-10-06
Midodrine Use in Septic Shock
Midodrine Hydrochloride, placebo - Septic Shock
Phase 3TerminatedUniversity of Virginia102018-11-052025-09-24
Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock
Triple therapy group - Septic Shock, Critical Illness
Phase 2 / Phase 3TerminatedHamad Medical Corporation1062018-03-172021-12-10

Showing 20 of 77. Sign in to see all of them.

Narrower conditions

Sepsis (24)  ·  Shock, Septic (15)  ·  Bacteremia (6)  ·  Candidemia (5)  ·  Cytokine Release Syndrome (5)  ·  Respiratory Distress Syndrome (5)  ·  COVID-19 (4)  ·  Critical Illness (4)  ·  Abscess (3)  ·  Acute Kidney Injury (3)  ·  Candidiasis (3)  ·  Candidiasis, Invasive (3)  ·  Fibrosis (3)  ·  Mycoses (3)

Broader conditions

Pathological Conditions, Signs and Symptoms (77)  ·  Pathologic Processes (76)  ·  Infections (57)  ·  Systemic Inflammatory Response Syndrome (49)  ·  Shock (22)  ·  Sepsis (21)  ·  Respiratory Tract Diseases (16)  ·  Bacterial Infections and Mycoses (13)  ·  Lung Diseases (11)  ·  Cardiovascular Diseases (10)  ·  Respiratory Tract Infections (9)  ·  Urogenital Diseases (9)  ·  Vascular Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (8)

Interventions

Sodium Chloride (8)  ·  Saline Solution (5)  ·  Hydrocortisone (4)  ·  Ascorbic Acid (3)  ·  Daptomycin (3)  ·  Thiamine (3)  ·  Vancomycin (3)  ·  Albumins (2)  ·  Anidulafungin (2)  ·  Fluconazole (2)  ·  Glutamine (2)  ·  Meropenem (2)  ·  Micafungin (2)  ·  Serum Albumin, Human (2)  ·  Sugars (2)

Sponsors

Pfizer (5)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Centre Hospitalier Universitaire Dijon (2)  ·  Emory University (2)  ·  University of Versailles (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Astellas Pharma Global Development, Inc. (1)  ·  Bausch & Lomb Incorporated (1)  ·  Baystate Medical Center (1)  ·  Beneficência Portuguesa de São Paulo (1)  ·  Centre Francois Baclesse (1)  ·  Centre Hospitalier Régional d'Orléans (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Christiana Care Health Services (1)

Countries

United States (30)  ·  France (16)  ·  Canada (11)  ·  Italy (8)  ·  Spain (8)  ·  Brazil (7)  ·  Germany (7)  ·  Greece (5)  ·  Israel (5)  ·  Netherlands (5)  ·  Belgium (4)  ·  Bulgaria (4)  ·  Denmark (4)  ·  Russia (4)  ·  Colombia (3)

Top investigators

Abbot R. Laptook, MD (1)  ·  Adham Mohamed, PharmD (1)  ·  Alexander Rombauts (1)  ·  Alexander Wilmer, MD, PhD (1)  ·  Alexandra Kadl, MD (1)  ·  Amanda Conti, MD (1)  ·  Anders Kjellberg, MD (1)  ·  Annetine C Gelijns, PhD (1)  ·  Arlene A Stecenko, MD (1)  ·  Bairbre Connolly, MD (1)  ·  Borja Ibanez, MD PhD FESC (1)

Results publications

PMID 28459966, PMID 28597967, PMID 33891293, PMID 10722036, PMID 1138591, PMID 11502226, PMID 12454520, PMID 12545007, PMID 12700374, PMID 16000352, PMID 1607900, PMID 16570523, PMID 17443204, PMID 17517240, PMID 17586184, PMID 18337740, PMID 18353115, PMID 19067285, PMID 20332511, PMID 20459801, PMID 20591191, PMID 20646908, PMID 20844049, PMID 20946227, PMID 21988742, PMID 22059409, PMID 22079954, PMID 22120766, PMID 227054, PMID 23525934, PMID 23549582, PMID 24484547, PMID 24835849, PMID 24838355, PMID 25463545, PMID 25466837, PMID 26631058, PMID 26771781, PMID 26832963, PMID 26903338, PMID 26936876, PMID 27162802, PMID 27585969, PMID 27695824, PMID 27940189, PMID 28098591, PMID 28732314, PMID 29247809, PMID 29325753, PMID 29388815

NIH funding

2014 (2), 2018 (2), M01RR000032 (1), M01RR000044 (1), M01RR000070 (1), M01RR000633 (1), M01RR000750 (1), M01RR006022 (1), M01RR007122 (1), M01RR008084 (1), M01RR016587 (1), N01HR056179 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1)